Business ❯Pharmaceuticals ❯Drug Development
Acute Myeloid Leukemia Checkpoint Therapeutics Therapies ISB 2001 Clinical Trials
Brokerages boost forecasts as Glenmark deploys an upfront payment to accelerate oncology research.
